Smead Capital Management Inc. increased its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 23.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 901,985 shares of the pharmacy operator’s stock after buying an additional 168,475 shares during the period. Walgreens Boots Alliance accounts for approximately 3.8% of Smead Capital Management Inc.’s portfolio, making the stock its 13th largest position. Smead Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $74,910,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. AE Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter valued at $428,000. Fort Washington Investment Advisors Inc. OH increased its stake in shares of Walgreens Boots Alliance by 4.6% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 11,460 shares of the pharmacy operator’s stock valued at $952,000 after buying an additional 500 shares in the last quarter. Tredje AP fonden increased its stake in shares of Walgreens Boots Alliance by 5.1% in the first quarter. Tredje AP fonden now owns 86,351 shares of the pharmacy operator’s stock valued at $7,171,000 after buying an additional 4,187 shares in the last quarter. Venturi Wealth Management LLC increased its stake in shares of Walgreens Boots Alliance by 8.5% in the first quarter. Venturi Wealth Management LLC now owns 37,860 shares of the pharmacy operator’s stock valued at $3,136,000 after buying an additional 2,950 shares in the last quarter. Finally, Cornerstone Capital Management Holdings LLC. increased its stake in shares of Walgreens Boots Alliance by 30.0% in the first quarter. Cornerstone Capital Management Holdings LLC. now owns 288,216 shares of the pharmacy operator’s stock valued at $23,935,000 after buying an additional 66,580 shares in the last quarter. 61.17% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 81.51 on Tuesday. The company has a 50-day moving average of $78.82 and a 200-day moving average of $82.40. The stock has a market capitalization of $87.22 billion, a price-to-earnings ratio of 20.58 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 52 week low of $75.18 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period in the prior year, the business posted $1.18 earnings per share. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. Analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current year.

Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase up to 5.9% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be given a dividend of $0.40 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 1.96%. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio is presently 37.78%.

COPYRIGHT VIOLATION NOTICE: This report was published by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/08/smead-capital-management-inc-has-74-91-million-stake-in-walgreens-boots-alliance-inc-nasdaqwba.html.

Several brokerages have weighed in on WBA. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 3rd. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Monday, July 17th. Credit Suisse Group reaffirmed a “buy” rating and set a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Leerink Swann set a $86.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Friday, July 7th. Finally, Citigroup Inc. reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $90.69.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.